About Apitope
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.
Apitope is a biotech company focused on the discovery and development of disease modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis. The company, whose first product candidate is licensed to Merck Serono, will now progress its remaining portfolio of product candidates developed with its proprietary platform technology.
Company Highlights
Year Founded
2002
Employees
3
Location (HQ)
BEL
Since Last Funding
8 years 11 months
Monthly Website Visitors
212
Total Investment Amt
$26M
Last Funding Round
Series B
Key Metrics
Senior Hires
Name | Linkedin Profile | Position | Date Joined |
---|---|---|---|
John Doe | https://www.linkedin.com/in/johndoe | CEO | CEO |
Jane Doe | https://www.linkedin.com/in/janedoe | CTO | CTO |
John Smith | https://www.linkedin.com/in/johnsmith | CFO | CFO |
Jane Smith | https://www.linkedin.com/in/janesmith | COO | COO |
Similar Companies
- APAC BIOTECHApellis PharmaceuticalsImmunomeAimmune TherapeuticsApexigenApollomicsAbata TherapeuticsAristea TherapeuticsArtax BiopharmaApic BioSeranova BioAlladapt ImmunotherapeuticsAptevo TherapeuticsInimmuneIMMvention TherapeutixApoGen BiotechnologiesVersatope TherapeuticsIMTherapeuticsAnaphoreMeditope BiosciencesEpitopeaRetrotopePathios TherapeuticsApexian PharmaceuticalsEpitomee MedicalAtopix TherapeuticsPeptinnovateAlba TherapeuticsAmplimmuneAvidiaApoteaAnokionTopas TherapeuticsAntag TherapeuticsApogenixAptaTargetsMETA PharmaceuticalsAdageneTolerionIpiNovyx BioSuppreMolPeptimmuneArtielle ImmunoTherapeuticsAptitude Medical SystemsEpiBiologicsApogee TherapeuticsAprogenMitoimmune TherapeuticsACtion PharmaAvotresIMMUNETHEPApoglyxGenesenAplife BiotechAlzinova AB
Biotechnology
- CryptobiotixConvert PharmaceuticalsBIOKET Bioeconomy Key Enabling Technologies platformAsylia DiagnosticsAsylia DiagnosticsbippGenflow BiosciencesGenflow BiosciencesTransloMONA.healthAmyl TherapeuticsWishboneOHMX.bioPigenFormac PharmaceuticalsAllegro BiotechPromethera BiosciencesPromethera BiosciencesCartageniaBIPPOpus MedicalUgenTecUgenTecAmalus TherapeuticsPronotaActoGeniXActoGeniXAntelope DxAntelope DxDeuterOncologyDeuterOncologyABSCINTEuropean Society of Gene and Cell TherapyAbnomX
Biotechnology Research
- CryptobiotixBIOKET Bioeconomy Key Enabling Technologies platformPharmaeconomica BVAsylia DiagnosticsbippGenflow BiosciencesDomobiosObulytixAmyl TherapeuticsWakatiOHMX.bioPigenPromethera BiosciencesCannovexCartageniaBIPPTenbeoSilicoGenesisUgenTec2GrowCAnnovexAmalus TherapeuticsNovalis BiotechReGenesys BVActoGeniXBioRICSOrgenesis BelgiumBISC GlobalAntelope DxDeuterOncologyNeuvasq BiotechnologiesAgricells SAABSCINTThe ProteInn ClubSwiftPharmaAbnomX
Medical
Health Care
- TooddocAsylia DiagnosticsPhasyaGenflow BiosciencesDomobiosRuneasiArt SmileTransloMONA.healthNextGenicsAmyl TherapeuticsWishboneNOÖSR-techFormac PharmaceuticalsPromethera BiosciencesMiracor MedicalCicaluxEpihunterPAwaZinkhqointaRekruutDim3PharmasimpleOncomfortNeuroventisImageLevel6WolvesKoios CareAmalus TherapeuticsXetalPronotaHeartKineticsProfilityCARDIATIS, SABe-Care SRLGlamSmileABSCINTNateenPFMD .org